Literature DB >> 21969812

Invasion precedes tumor mass formation in a malignant brain tumor model of genetically modified neural stem cells.

Oltea Sampetrean1, Isako Saga, Masaya Nakanishi, Eiji Sugihara, Raita Fukaya, Nobuyuki Onishi, Satoru Osuka, Masaki Akahata, Kazuharu Kai, Hachiro Sugimoto, Atsushi Hirao, Hideyuki Saya.   

Abstract

Invasiveness, cellular atypia, and proliferation are hallmarks of malignant gliomas. To effectively target each of these characteristics, it is important to understand their sequence during tumorigenesis. However, because most gliomas are diagnosed at an advanced stage, the chronology of gliomagenesis milestones is not well understood. The aim of the present study was to determine the onset of these characteristics during tumor development. Brain tumor-initiating cells (BTICs) were established by overexpressing H-Ras(V12) in normal neural stem/progenitor cells isolated from the subventricular zone of adult mice harboring a homozygous deletion of the Ink4a/Arf locus. High-grade malignant brain tumors were then created by orthotopic implantation of 10(5) BTICs into the forebrain of 6-week-old wild-type mice. Micewere killed every week for 5 weeks, and tumors were assessed for cellular atypia, proliferation, hemorrhage, necrosis, and invasion. All mice developed highly invasive, hypervascular glioblastoma-like tumors. A 100% penetrance rate and a 4-week median survival were achieved. Tumor cell migration along fiber tracts started within days after implantation and was followed by perivascular infiltration of tumor cells with marked recruitment of reactive host cells. Next, cellular atypia became prominent. Finally, mass proliferation and necrosis were observed in the last stage of the disease. Video monitoring of BTICs in live brain slices confirmed the early onset of migration, as well as the main cell migration patterns. Our results showed that perivascular and intraparenchymal tumor cell migration precede tumor mass formation in the adult brain, suggesting the need for an early and sustained anti-invasion therapy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21969812      PMCID: PMC3182271          DOI: 10.1593/neo.11624

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  31 in total

1.  Astrocyte-specific expression of activated p21-ras results in malignant astrocytoma formation in a transgenic mouse model of human gliomas.

Authors:  H Ding; L Roncari; P Shannon; X Wu; N Lau; J Karaskova; D H Gutmann; J A Squire; A Nagy; A Guha
Journal:  Cancer Res       Date:  2001-05-01       Impact factor: 12.701

2.  Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice.

Authors:  E C Holland; J Celestino; C Dai; L Schaefer; R E Sawaya; G N Fuller
Journal:  Nat Genet       Date:  2000-05       Impact factor: 38.330

Review 3.  Stem cells, cancer, and cancer stem cells.

Authors:  T Reya; S J Morrison; M F Clarke; I L Weissman
Journal:  Nature       Date:  2001-11-01       Impact factor: 49.962

4.  A comparison of the migration patterns of normal and malignant cells in two assay systems.

Authors:  J Varani; W Orr; P A Ward
Journal:  Am J Pathol       Date:  1978-01       Impact factor: 4.307

Review 5.  Gliomagenesis: genetic alterations and mouse models.

Authors:  E C Holland
Journal:  Nat Rev Genet       Date:  2001-02       Impact factor: 53.242

6.  Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas.

Authors:  K S Aboody; A Brown; N G Rainov; K A Bower; S Liu; W Yang; J E Small; U Herrlinger; V Ourednik; P M Black; X O Breakefield; E Y Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

Review 7.  Targeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastoma.

Authors:  Jason T Huse; Eric C Holland
Journal:  Nat Rev Cancer       Date:  2010-05       Impact factor: 60.716

8.  Ink4a-Arf loss cooperates with KRas activation in astrocytes and neural progenitors to generate glioblastomas of various morphologies depending on activated Akt.

Authors:  Lene Uhrbom; Chengkai Dai; Joseph C Celestino; Marc K Rosenblum; Gregory N Fuller; Eric C Holland
Journal:  Cancer Res       Date:  2002-10-01       Impact factor: 12.701

9.  Glioma tropic neural stem cells consist of astrocytic precursors and their migratory capacity is mediated by CXCR4.

Authors:  Moneeb Ehtesham; Xiangpeng Yuan; Peter Kabos; Nancy H C Chung; Gentao Liu; Yasuharu Akasaki; Keith L Black; John S Yu
Journal:  Neoplasia       Date:  2004 May-Jun       Impact factor: 5.715

10.  Identification of a cancer stem cell in human brain tumors.

Authors:  Sheila K Singh; Ian D Clarke; Mizuhiko Terasaki; Victoria E Bonn; Cynthia Hawkins; Jeremy Squire; Peter B Dirks
Journal:  Cancer Res       Date:  2003-09-15       Impact factor: 12.701

View more
  45 in total

1.  The interconnectedness of cancer cell signaling.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2011-12       Impact factor: 5.715

2.  N-cadherin upregulation mediates adaptive radioresistance in glioblastoma.

Authors:  Satoru Osuka; Dan Zhu; Zhaobin Zhang; Chaoxi Li; Christian T Stackhouse; Oltea Sampetrean; Jeffrey J Olson; G Yancey Gillespie; Hideyuki Saya; Christopher D Willey; Erwin G Van Meir
Journal:  J Clin Invest       Date:  2021-03-15       Impact factor: 14.808

3.  Correlations of MGMT genetic polymorphisms with temozolomide resistance and prognosis of patients with malignant gliomas: a population-based study in China.

Authors:  H-W Wang; Z-K Xu; Y Song; Y-G Liu
Journal:  Cancer Gene Ther       Date:  2017-04-14       Impact factor: 5.987

Review 4.  Overcoming therapeutic resistance in glioblastoma: the way forward.

Authors:  Satoru Osuka; Erwin G Van Meir
Journal:  J Clin Invest       Date:  2017-02-01       Impact factor: 14.808

5.  Cancer subclonal genetic architecture as a key to personalized medicine.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2013-12       Impact factor: 5.715

6.  Constitutive activation of myosin-dependent contractility sensitizes glioma tumor-initiating cells to mechanical inputs and reduces tissue invasion.

Authors:  Sophie Y Wong; Theresa A Ulrich; Loic P Deleyrolle; Joanna L MacKay; Jung-Ming G Lin; Regina T Martuscello; Musa A Jundi; Brent A Reynolds; Sanjay Kumar
Journal:  Cancer Res       Date:  2015-01-29       Impact factor: 12.701

7.  CXCL12 secreted from glioma stem cells regulates their proliferation.

Authors:  Youji Uemae; Eiichi Ishikawa; Satoru Osuka; Masahide Matsuda; Noriaki Sakamoto; Shingo Takano; Kei Nakai; Tetsuya Yamamoto; Akira Matsumura
Journal:  J Neurooncol       Date:  2014-01-19       Impact factor: 4.130

8.  Low Concentration Microenvironments Enhance the Migration of Neonatal Cells of Glial Lineage.

Authors:  Richard A Able; Celestin Ngnabeuye; Cade Beck; Eric C Holland; Maribel Vazquez
Journal:  Cell Mol Bioeng       Date:  2012-06       Impact factor: 2.321

Review 9.  Glioblastoma stem cells: Molecular characteristics and therapeutic implications.

Authors:  Nermin Sumru Bayin; Aram Sandaldjian Modrek; Dimitris George Placantonakis
Journal:  World J Stem Cells       Date:  2014-04-26       Impact factor: 5.326

10.  Neuromorphometry of primary brain tumors by magnetic resonance imaging.

Authors:  Nidiyare Hevia-Montiel; Pedro I Rodriguez-Perez; Paul J Lamothe-Molina; Alfonso Arellano-Reynoso; Ernesto Bribiesca; Marco A Alegria-Loyola
Journal:  J Med Imaging (Bellingham)       Date:  2015-05-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.